Annex 3. Checklist for TB infection prevention and control
This annex is based on a tool produced by Médecins Sans Frontières (MSF) and Partners in Health. (1)
This annex is based on a tool produced by Médecins Sans Frontières (MSF) and Partners in Health. (1)
Ongoing monitoring of collaborative TB/HIV activities and evaluation of their impact is critically important for driving scale-up and for monitoring progress and identifying gaps in implementation. This requires an effective and efficient monitoring and evaluation system.
Table A1.1 summarizes the core indicators recommended for monitoring and evaluating collaborative TB/HIV activities. The indicators are categorized as core indicators for global and national monitoring and reporting, and core indicators for national-level monitoring and reporting only.
4.3.1 Combination HIV prevention for people with diagnosed or presumed TB
National TB programmes should implement comprehensive HIV prevention strategies for their clients and their partners, or they should establish community and referral linkages as necessary. HIV preventive interventions by TB programmes or effective referral of people with TB to HIV programmes has been successfully implemented in many countries (162-164).
3.5.1 TB preventive treatment
3.4.1 WHO-recommended treatment regimens for adults with drug-susceptible TB